A new study published in the Journal of Psychopharmacology is the first to characterize the psychological impacts of psilocybin among people with bipolar disorder.
The findings indicate that many people with bipolar disorder who consume psilocybin, the primary psychoactive component of psychedelic “magic mushrooms,” believe that the experience is helpful. However, many also report adverse outcomes, such as manic symptoms.
Read more
"Aha” moments in psychedelic therapy can offer unique insight and perspective. But some insights are false and others may ring true.
Read more
Check out this podcast from Psychedelics Today~~ with New York Times best-selling author, pioneer in the field of integrative medicine, and overall legend in the health and wellness space: Andrew Weil, M.D.
Read more
Here’s the official statement from MAPS!
The results confirmed findings from MAPP1; no serious adverse events were observed among the participants
In a first for psychedelic-assisted therapy trials, more than half of MAPP2 participants identify as people of color
Read more
Here’s a good article on the benefits of psychedelics, but set and setting, and therapy are important.
Read more
Some studies have begun to investigate the relationship between CBD and psychedelics… Especially the practice of using CBD to stop SSRI use, which you should wean before using a psychedelic.
Read more
Visiting with family and friends for the holidays, and wanting to talk about psychedelics? This handy guide can help!
Read more